ProCE Banner Activity

CE / CME

Clinical Challenges of IBD Management: Racial Disparities in IBD and COVID Updates

Video

An expert in IBD discusses strategies for decreasing disparities and preventing and treating COVID-19 in those with IBD. This is the fifth module in a robust IBD Core Curriculum program from Clinical Care Options (CCO) and Practicing Clinicians Exchange (PCE).

Nurse Practitioners: 0.25 Nursing contact hours, includes 0.25 hour of pharmacotherapy credit

Physician Assistants/Physician Associates: 0.25 AAPA Category 1 CME credit

Physicians: maximum of 0.25 AMA PRA Category 1 CreditTM

Released: January 20, 2023

Expiration: January 19, 2024

No longer available for credit.

Share

Faculty

Abigail Meyers

Abigail Meyers, PA-C

Instructor in Surgery
Physician Assistant
Colon and Rectal Surgery
Mayo Clinic
Rochester, Minnesota

Provided by

Provided by the American Gastroenterological Association and Partners for Advancing Clinical Education, in partnership with Practicing Clinicians Exchange and Clinical Care Options, LLC

ProCE Banner
ProCE Banner

Supporters

This activity is supported by educational grants from

Amgen, Inc.

Ferring Pharmaceuticals, Inc.

Takeda Pharmaceuticals U.S.A., Inc.

Partners

Clinical Care Options, LLC

ProCE Banner

Practicing Clinicians Exchange

ProCE Banner

Target Audience

This program is intended for the IBD care team including gastroenterologists, advanced practice providers that specialize in gastroenterology, internal medicine and family medicine physicians and advanced practice providers, nurses and other HCPs involved in the care of patients living with IBD.

Program Learning Goal

The goal of this multicomponent, multiformat curriculum is to improve the knowledge and competence of community HCPs who care for patients living with ulcerative colitis and Crohn’s disease.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Apply strategies to reduce racial disparities impacting patients with IBD
  • Summarize the latest recommendations and best practices for the management of IBD during COVID-19

Disclosure

All faculty and planners participating in continuing education activities sponsored by Partners for Advancing Clinical Education (PACE) are required to disclose all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PACE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Abigail Meyers, PA-C, has no relevant financial relationships to disclose.

The planners and content peer reviewers from Partners for Advancing Clinical Education, the American Gastroenterological Associate, Practicing Clinicians Exchange, and Clinical Care Options, LLC do not have any relevant financial relationships to disclose, except Bruce E. Sands, MD, MS and Kimberly Kearns, MS, APN-BC as noted below:

Bruce E. Sands, MD, MS: consultant/advisor/speaker: AbbVie, Amgen, Arena Pharmaceuticals, AstraZeneca, Boehringer-Ingelheim, Bristol Myers Squibb, Celltrion, Fresenius Kabi, Genentech, GlaxoSmithKline, Janssen, Lilly, Merck, Pfizer, Sun Pharma, Takeda, Teva.

Kimberly Kearns, MS, APN-BC: consultant/advisor/speaker: Lilly, Janssen, Salix.

Instructions for Credit

Learners wishing to earn CE/CME credit must:

  1. View the content in its entirety
  2. Relate the content material to the learning objectives
  3. Complete evaluation form

The estimated time to complete this activity is 0.25 hours.

Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of 65%.

Format

This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accreditation

Accreditation Statement
The AGA Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation
The AGA Institute designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Joint Accreditation Statement
Joint AccreditationIn support of improving patient care, Partners for Advancing Clinical Education (PACE) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

ANCC Credit Designation
Nursing contact hours: 0.25, which includes 0.25 hours of pharmacology credit
Nurse Course Advisor: Kimberly Kearns, MS, APN-BC, Duly Health and Care, Hoffman Estates, Illinois

AAPA Credit Designation
Joint AccreditationPartners for Advancing Clinical Education (PACE) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credits for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credits. Approval is valid until January 19, 2024. PAs should only claim credit commensurate with the extent of their participation.

PA Course Advisor: Abigail Meyers, PA-C, Mayo Clinic, Rochester, Minnesota